Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event
affecting patients with cancer and patients with osteoporosis who have been treated with …

MicroComputed Tomography has become the gold standard for studying 3D microscopic
structures nondestructively, and this book provides up-to-date coverage of the modality. The …

Objective The main aim is to identify, by means of different imaging modalities, the early
bone changes in patients “at risk” and in stage 0 MRONJ. Materials and methods A search of …

Objective This study was performed to determine whether the results of prevailing in vivo
and in vitro studies offer a reliable model for investigation of medication-related …

Medication-related osteonecrosis of the jaw (MRONJ) is characterized by bone exposure for
more than eight weeks in patients who have used or been treated with antiresorptive or …

Objectives To investigate the extension of experimentally induced peri-implantitis lesions
under various antiresorptive and antiangiogenic medications. Material and methods Fourty …

Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive
(AR) drugs such as bisphosphonates (BP) and denosumab (Dmab). Although several risk …

Objective This study aimed to investigate the effect of risedronate on orthodontic tooth
movement in ovariectomized rats. Methods Forty-five female Sprague-Dawley rats were …

Purpose: To compare radiographic predictors of medication-related osteonecrosis of the jaw
in dental extraction sites. Materials and methods: Forty-one oncological patients undergoing …

Bisphosphonate (BP) discontinuation has been advised as a measure to prevent the
incidence of bisphosphonate-related osteonecrosis of the jaw (BRONJ), however, its efficacy …